Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Trends in Neurosciences|April 1, 1996
Which GABAA-receptor subtypes really occur in the brain?R M McKernan, P J WhitingNeuropharmacology|January 1, 1986
Phenoxybenzamine partially inhibits alpha 2-adrenoceptors without affecting their presynaptic functionR M McKernan, I C CampbellBritish Journal of Pharmacology|March 2, 1999
Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulinA J Smith, R M McKernanBrain Research|April 17, 1992
CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke modelR H Hatfield, R M McKernanBrain Research|May 7, 1986
Clorgyline and desipramine alter the sensitivity of [3H]noradrenaline release to calcium but not to clonidineI C Campbell, R M McKernanMolecular Membrane Biology|January 1, 1994
Characterization of the solubilized NMDA receptor complex from rat brain with [3H]L-689,560, a glycine site antagonistK Quirk, A C Foster, R M McKernanProceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation siteP Whiting, R M McKernan, L L IversenBritish Journal of Pharmacology|March 7, 2007
Characterization of [35S]t-butylbicyclophosphorothionate ([35S]TBPS) binding to GABAA receptors in postmortem human brainJ R Atack, Y Ohashi, R M McKernanEuropean Journal of Pharmacology|December 1, 1998
Benzodiazepine modulation of recombinant alpha1beta3gamma2 GABA(A) receptor function efficacy determination using the Cytosensor microphysiometerA J Smith, R M McKernan, J R AtackAnnual Review of Pharmacology and Toxicology|January 1, 1987
Metabolism of alpha- and beta-adrenergic receptors in vitro and in vivoL C Mahan, R M McKernan, P A InselPageof 6